Repro Med Profile

USD 0.02  1.75%

Repro Med exotic insider transaction detected

Repro Med Systems Inc insider trading alert for general transaction of common stock by Joseph Manko, the corporate stakeholder, on March 16, 2018. This event was filed by Repro Med Systems Inc with SEC on 2018-03-16. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Repro Med Summary

Repro Med Systems (REPR) is traded on OTC Market in USA. It is located in NEW YORK, U.S.A and employs 73 people. Repro Med is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 44.1 M. Repro Med Systems conducts business under Healthcare sector and is part of Medical Equipment industry. This company has 38.02 M outstanding shares. REPRO MED SYS INC currently holds about 4.24 M in cash with 1.08 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.11.
Check Repro Med Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 69.85%30 days 1.16  about 30.09%
Based on normal probability distribution, the odds of Repro Med to move above current price in 30 days from now is about 30.09% (This Repro Med Systems probability density function shows the probability of Repro Med Stock to fall within a particular range of prices over 30 days) .

Selected Repro Med Systems Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Repro Med Against Markets

Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
< 43% 
Equity ratings for Repro Med Systems are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Repro Med Systems, Inc. designs, manufactures, and markets proprietary portable medical devices and supplies primarily for the ambulatory infusion market and emergency medical applications worldwide. Repro Med Systems, Inc. was founded in 1980 and is headquartered in Chester, New York. Repro Med operates under Medical Instruments Supplies classification in USA and traded on OTC Market. It employs 73 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
NameRepro Med Systems
ChairmanAndrew SealfonView All
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
LocationNEW YORK, U.S.A
Business Address24 Carpenter Road
ExchangeOTC Market
IndustryMedical Equipment
Contact Number845 469 2042
CurrencyUSD - US Dollar

Diversify with Repro Med Systems

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Repro Med Systems to your portfolio


Repro Med Corporate Directors
Mark Pastreich Director
Daniel Goldberger Independent Director
Cyril Narishkin Interim COO and Additional Director
Additionally take a look at Your Equity Center. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.